Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Miao L, Li L, Huang Y, Delcassian D, Chahal J, Han J, Shi Y, Sadtler K, Gao W, Lin J, Doloff JC, Langer R, Anderson DG. Nat Biotechnol. 2019 Sep 30. PubMed
Hybrid Mouse Diversity Panel Identifies Genetic Architecture Associated with the Acute Antisense Oligonucleotide-Mediated Inflammatory Response to a 2′-O-Methoxyethyl Antisense Oligonucleotide
Pirie E, Cauntay P, Fu W, Ray S, Pan C, Lusis AJ, Hsiao J, Burel SA, Narayanan P, Crooke RM, Lee RG. Nucleic Acid Ther. 2019 Aug 1. PubMed
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes
Schleimann MH, Kobberø ML, Vibholm LK, Kjær K, Giron LB, Busman-Sahay K, Chan CN, Nekorchuk M, Schmidt M, Wittig B, Damsgaard TE, Ahlburg P, Hellfritzsch MB, Zuwala K, Rothemejer FH, Olesen R, Schommers P, Klein F, Dweep H, Kossenkov A, Nyengaard JR, Estes JD, Abdel-Mohsen ...
Morpholinos Do Not Elicit an Innate Immune Response during Early Xenopus Embryogenesis
Paraiso KD, Blitz IL, Zhou JJ, Cho KWY. Dev Cell. 2019 May 20;49(4):643-650.e3. PubMed
Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated ‘don’t-eat-me’ signal
Liu M, O'Connor RS, Trefely S, Graham K, Snyder NW, Beatty GL. Nat Immunol. 2019 Jan 21. PubMed
Activation of Innate Immune Responses by a Cytosine-Phosphate-Guanine Oligonucleotide Sequence Composed Entirely of Threose Nucleic Acid
Lange MJ, Burke DH, Chaput JC. Nucleic Acid Ther. 2018 Dec 11. PubMed
RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade
Ganesh S, Shui X, Craig KP, Park J, Wang W, Brown BD, Abrams MT. Mol Ther. 2018 Nov 7;26(11):2567-2579 PubMed
DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination
Hayashi T, Momota M, Kuroda E, Kusakabe T, Kobari S, Makisaka K, Ohno Y, Suzuki Y, Nakagawa F, Lee MSJ, Coban C, Onodera R, Higashi T, Motoyama K, Ishii KJ, Arima H. Front Immunol. 2018 Nov 20;9:2619. PubMed
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells
Kell SA, Kachura MA, Renn A, Traquina P, Coffman RL, Campbell JD. Int Immunopharmacol. 2018 Nov 28;66:296-308. PubMed
STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
Moreira D, Adamus T, Zhao X, Su YL, Zhang Z, White SV, Swiderski P, Lu X, DePinho RA, Pal SK, Kortylewski M. Clin Cancer Res. 2018 Oct 18. PubMed
